Alterity Therapeutics Announces Allowance of New Composition of Matter Patent by the United States Patent and Trademark Office December 29, 2022December 29, 2022
Further Information – Prana’s PBT2 Clinical Trials Cited as Most Advanced in Addressing Neurodegeneration from the Metal Equilibrium Perspective July 17, 2013August 16, 2022
Prana Announces that New York Academy of Sciences eBriefing available online July 17, 2013August 16, 2022